Publications by authors named "CHuanhao Tang"

Article Synopsis
  • FGFR is a vital receptor involved in growth and tissue repair, but its gene mutations can lead to cancer by disrupting essential processes.
  • Small molecule drugs and antibodies targeting FGFR mutations, like erdafitinib and pemigatinib, have shown clinical efficacy in treating certain cancer types.
  • Effective screening methods for FGFR variants are essential for utilizing FGFR inhibitors in treatment, and a consensus has been developed to standardize diagnosis and treatment processes.
View Article and Find Full Text PDF
Article Synopsis
  • * BRAF mutations are common in various cancers, and targeted therapies, especially BRAF inhibitors like dabrafenib and trametinib, are developed for treating solid tumors with these mutations.
  • * An expert consensus has been established to improve the diagnosis and treatment of solid tumors with BRAF mutations, focusing on summarizing their clinical features, recommending genetic testing methods, and creating a systematic approach for patient care.
View Article and Find Full Text PDF

The complex electromagnetic applications in harsh corrosive environments urgently require research into multifunctional microwave absorption (MA) materials. The core-shell structure is an effective strategy to prepare multifunctional MA materials by efficiently combining the advantages of each component. Nevertheless, it remains a tough challenge to elucidate the effect of the binding positions of each component in MA materials on the comprehensive electromagnetic performance.

View Article and Find Full Text PDF

Extracellular vesicles (EVs) are considered as promising candidates for predicting patients who respond to immunotherapy. Nevertheless, simultaneous detection of multiple EVs markers still presents significant technical challenges. In this work, we developed a high-throughput microdroplet-enhanced chip (MEC) platform, which utilizes thousands of individual microchambers (∼pL) as reactors, accelerating the detection efficiency of the CRISPR/Cas systems and increasing the sensitivity by up to 100-fold (aM level).

View Article and Find Full Text PDF
Article Synopsis
  • * About 50% of patients with bone metastasis face serious complications known as skeletal related events (SREs), which drastically affect their quality of life and survival.
  • * To improve diagnosis and treatment for bone metastasis in lung cancer, a multi-disciplinary team has created an expert consensus for standardizing care approaches.
View Article and Find Full Text PDF

Besides programmed death ligand 1 (PD-L1) expression, rapid, cost-effective and validated scores or models are critical for the prognosis and prediction of patients received immune checkpoint inhibitors (ICIs). In this retrospective study, 182 patients with NSCLC receiving ICIs from 2015 to 2022 were divided 1:1 into a training cohort and a validation cohort. We identified a score established by three factors and analyzed the prognostic implications by Kaplan-Meier approach (Log rank test) and time-dependent receiver operating characteristic (ROC) analyses.

View Article and Find Full Text PDF
Article Synopsis
  • Fusion genes from the epidermal growth factor (EGF) receptor family are significant players in cancer development, especially in lung cancer, where gene fusion incidence is 0.19 to 0.27%.
  • Common partners for these fusions are CD74 and SLC3A2, and detection methods include RNA-based next-generation sequencing and pERBB3 immunohistochemistry for quick screening.
  • Currently, there are no approved specific drugs for these fusions, but treatment options like pan-ERBB inhibitors and monoclonal antibodies are being explored, with clinical trials aiming to improve outcomes for patients with solid tumors containing these gene fusions.
View Article and Find Full Text PDF

Background: Limited response to programmed death ligand-1 (PD-L1)/programmed death 1 (PD-1) immunotherapy is a major hindrance of checkpoint immunotherapy in non-small cell lung cancer (NSCLC). The abundance of PD-L1 on the tumor cell surface is crucial for the responsiveness of PD-1/PD-L1 immunotherapy. However, the negative control of PD-L1 expression and the physiological significance of the PD-L1 inhibition in NSCLC immunotherapy remain obscure.

View Article and Find Full Text PDF
Article Synopsis
  • The RET gene is a receptor tyrosine kinase involved in cell growth and differentiation; its fusion is a rare but poor-prognosis alteration in non-small cell lung cancer (NSCLC).
  • Two selective inhibitors, pralsetinib and selpercatinib, have been approved for treating RET fusion NSCLC, showing effectiveness against resistance to other treatments.
  • Effective patient screening for RET fusion is vital, utilizing methods like NGS, RT-PCR, FISH, and IHC, with the goal of standardizing approaches to improve diagnosis and therapy outcomes.
View Article and Find Full Text PDF

How to better understand the influence of electromagnetic parameters on the absorbing properties of electromagnetic wave absorbers (EMAs) is an essential prerequisite for further synthesis and development of high-performance EMAs. In this work, an improved wave cancellation theory is used as a guiding principle to prepare N-doped carbon-coated cobalt nanoparticles (Co@NC) using ZIF-8@ZIF-67 as the precursor, thus enabling controllable electromagnetic parameters by regulating the conduction loss and dipole polarization ability. The Co@NC generated by pyrolysis at 700 °C under H atmosphere presents an optimized absorption performance.

View Article and Find Full Text PDF

Malignant pleural mesothelioma (MPM) is a malignant tumor originating from the pleura, and its incidence has been increasing in recent years. Due to the insidious onset and strong local invasiveness of MPM, most patients are diagnosed in the late stage and early screening and treatment for high-risk populations are crucial. The treatment of MPM mainly includes surgery, chemotherapy, and radiotherapy.

View Article and Find Full Text PDF

The accurate diagnosis of pneumatosis intestinalis (PI) is increasing despite patients' limited identification of etiologic factors. Recently a patient with lung squamous carcinoma who developed pneumatosis intestinalis following methylprednisolone administration for immune-related adverse events was treated at our hospital. Subsequent a literature review and an analysis of the FDA Adverse Event Reporting System (FAERS) database enabled the identification of additional cases of pneumatosis intestinalis.

View Article and Find Full Text PDF

Thymic epithelial tumors (TETs) are a relatively rare type of thoracic tumor, accounting for less than 1% of all tumors. The incidence of TETs is about 3.93/10000 in China, slightly higher than that of European and American countries.

View Article and Find Full Text PDF

Human epidermal growth factor receptor 2 (HER2) possesses tyrosine kinase activity and participates in cell growth, differentiation and migration, and survival. Its alterations, mainly including mutations, amplifications, and overexpression are associated with poor prognosis and are one of the major drivers in non-small cell lung cancer (NSCLC). Several clinical trials had been investigating on the treatments of HER2-altered NSCLC, including conventional chemotherapy, programmed death 1 (PD-1) inhibitors, tyrosine kinase inhibitors (TKIs) and antibody-drug conjugates (ADCs), however, the results were either disappointing or encouraging, but inconsistent.

View Article and Find Full Text PDF

Immune checkpoint inhibitors (ICIs) have successfully treated a number of different types of cancer, which is of great significance for cancer treatment. With the widespread use of ICIs in clinical practice, the increasing checkpoint inhibitor pneumonia (CIP) will be a challenge to clinicians. To guide the diagnosis and treatment of CIP, we conducted in-depth discussions based on the latest evidence, forming a consensus among Chinese experts on the multidisciplinary management of CIP.

View Article and Find Full Text PDF

Gene fusions can drive tumor development for multiple types of cancer. Currently, many drugs targeting gene fusions are being approved for clinical application. At present, tyrosine receptor kinase (TRK) inhibitors targeting neurotrophic tyrosine receptor kinase (NTRK) gene fusions are among the first "tumor agnostic" drugs approved for pan-cancer use.

View Article and Find Full Text PDF

The design and development of radar--infrared compatible stealth materials are challenging in the field of broadband absorption due to the contradiction of stealth requirements and mechanisms in different frequency bands. However, hollow structures show great promise for multispectral stealth because they can lengthen the attenuation path of electromagnetic waves (EMWs) for microwave absorption, interrupt the continuity of heat-transport channels, and lower the thermal conductivity to realize infrared stealth. Here, a new morphological fabrication strategy has been developed to efficiently prepare compatible stealth nanomaterials.

View Article and Find Full Text PDF
Article Synopsis
  • Primary splenic angiosarcoma (PSA) is a rare and aggressive cancer with limited treatment options, and there is little research on immunotherapy for this condition.
  • A case study reports a 57-year-old woman with metastatic PSA who achieved a complete response after receiving a combination of the PD-1 inhibitor toripalimab and the VEGF inhibitor anlotinib.
  • This case provides early evidence that combining anti-PD-1 and anti-VEGF therapies could be promising for treating metastatic PSA, but further clinical trials are necessary to confirm these findings.
View Article and Find Full Text PDF

Immune checkpoint inhibitors (ICI) have transformed the treatment landscape of advanced non-small cell lung cancer (NSCLC). Biomarkers are essential for guiding precision immunotherapy. Tissue-based programmed death ligand 1 (PD-L1) expression and tumor mutational burden (TMB) are currently widely used biomarkers for selecting patients for immunotherapy.

View Article and Find Full Text PDF

Background: Droplet digital PCR (ddPCR)-based blood detection of EGFR mutations plays significant roles in the individualized therapy of non-small-cell lung cancer (NSCLC) patients. However, a standard assay that is approved by health authorities is still lacking. Additionally, the proper application of this method in clinical settings also needs further investigation.

View Article and Find Full Text PDF

Exosomes, which are 30-150 nm extracellular vesicles containing a variety of biomolecules (i.e., proteins, RNA, DNA, and lipids), have emerged as important analytes in liquid biopsy.

View Article and Find Full Text PDF

Objective: We investigated the correlations between cyclin-dependent kinase 4/6 (CDK4/6) levels and human papillomavirus (HPV) infection state in head and neck squamous cell cancer (HNSCC). The aim was to explore the potential value of CDK4/6 inhibitors in the treatment of HNSCC.

Methods: Multiomic sequencing data for HNSCC were obtained from The Cancer Genome Atlas (TCGA), and the mRNA levels and copy number variations (CNVs) of CDK4 and CDK6 were strictly analyzed.

View Article and Find Full Text PDF

Background: According to the literature and our experience, patients with gastrointestinal metastases are relatively rare. Numerous case reports and literature reviews have been reported. We present one of the larger case series of gastrointestinal metastases.

View Article and Find Full Text PDF

Matrix‑assisted laser desorption/ionization time‑of‑flight mass spectrometry (MALDI‑TOF‑MS) was employed to analyze differential serum and urine peptides in patients with small cell lung cancer (SCLC) and healthy individuals, and SCLC diagnostic classification models were constructed. Serum and urine samples from 72 patients with SCLC, age‑ and gender‑matched with 72 healthy individuals, were divided into training and testing sets in a 3:1 ratio. Serum and urine peptides were extracted using copper ion‑chelating nanomagnetic beads, and mass spectra were obtained using MALDI‑TOF‑MS.

View Article and Find Full Text PDF